Nurses Opinion on the Attributes of Polypharmacy in Patient Safety

  • John Lisha Jenny Mail Department of Pharmacology, Gulf Medical University, Ajman, UAE.
  • Cheriathu Jenny Department of Pediatrics, Gulf Medical College Hospital & Research Centre, Ajman, UAE.
  • Sreedharan Jayadevan Research Division, Gulf Medical University, Ajman, UAE.
  • Muttappallymyalil Jayakumary Research Division, Gulf Medical University, Ajman, UAE.
  • Arifulla Mohamed Department of Pharmacology, Gulf Medical University, Ajman, UAE.
  • Shirwaikar Arun College of Pharmacy, Gulf Medical University, Ajman, UAE
  • Fathi Mohamed Mohamed Department of Cardiology, Gulf Medical College Hospital & Research Centre, Ajman, UAE.
Keywords:
Polypharmacy, Negative outcomes, Opinion, Drug interactions

Abstract

Nurses play a functional role in preventing drug related problems. They need to be aware of the dangers of polypharmacy while reviewing patient medications. We studied the nurses’ opinion on the diverse effects of polypharmacy in the hospital setting. Nurses working in a tertiary care teaching hospital participated in this cross-sectional study, conducted over 3 months, by responding to a self-administered questionnaire. Chi-square test was used to analyze association between socio-demographic characteristics and items in the study. A value of P<0.05 was considered statistically significant. Increased drug interactions scored the highest (98.1%), followed by increased adverse drug effects (81.9%), and increase in financial burden (69.5%) among the negative effects of polypharmacy. 61% of the respondents felt that polypharmacy increased therapeutic effect in polypathology. No difference was observed in the opinion between male and female nurses or among varying nursing experience. Nurses with 5-10 years of experience opined increase in non-compliance to prescribed medication regimen and increase in financial burden also as negative attributes. Nurses pointed out both positive and negative implications of polypharmacy. Training programs such as continuing nursing education and workshops can be planned to translate this knowledge into practice in their routine nursing practice.

References

Viktil KK, Blix HS, Moger TA, Reikvam A.n Polypharmacy as commonly defined is an indicator of limited value in the assessment of drug-related problems. Br J Clin Pharmacol 2007;63(2):187-95.

Haider SI, Johnell K, Weitoft GR, Thorslund M, Fastbom J. The influence of educational level on polypharmacy and inappropriate drug use: a register-based study of more than 600,000 older people. J Am Geriatr Soc 2009;57(1):62-9.

Veehof L, Stewart R, Haaijer-Ruskamp F, Jong BM. The development of polypharmacy. A longitudinal study. FamPract 2000;17(3):261-7.

Barat I, Andreasen F, Damsgaard EM. The consumption ofdrugs by 75-year-old individuals living in their ownhomes. Eur J Clin Pharmacol 2000;56(6-7):501-9.

Junius-Walker U, Theile G, Hummers-Pradier E.Prevalence and predictors of polypharmacy among olderprimary care patients in Germany. Fam Pract 2007;24(1):14-9.

Koh Y, Kutty FB, Li SC. Drug-related problems in hospitalized patients on polypharmacy: the influence of age and gender. Ther Clin Risk Manag 2005;1(1):39-48.

Kingsbury SJ, Yi D, Simpson GM. Psychopharmacology: rational and irrational polypharmacy. Psychiatr Serv 2001;52(8):1033-6.

Bushardt RL, Massey EB, Simpson TW, Ariail JC, Simpson KN. Polypharmacy: misleading, but manageable. Clin Interv Aging 2008;3(2):383-9.

Gurwitz JH. Polypharmacy: a new paradigm for quality drug therapy in the elderly? Arch Intern Med 2004;164(18):1957-9.

Linjakumpu T, Hartikainen S, Klaukka T, Veijola J, Kivelä SL, Isoaho R. Use of medications and polypharmacy are increasing among the elderly. J Clin Epidemiol 2002;55(8):809-17.

Veehof L, Stewart R, Haaijer-Ruskamp F, Jong BM. The development of polypharmacy. A longitudinal study. Fam Pract 2000;17(3):261-7.

Ryan C, O'Mahony D, Kennedy J, Weedle P, Barry P, Gallagher P, Byrne S. Appropriate prescribing in the elderly: an investigation of two screening tools, Beers criteria considering diagnosis and independent of diagnosis and improved prescribing in the elderly tool to identify inappropriate use of medicines in the elderly in primary care in Ireland. J Clin Pharm Ther 2009;34(4):369-76.

Green JL, Hawley JN, Rask KJ. Is the number of prescribing physicians an independent risk factor for adverse drug events in an elderly outpatient population? Am J Geriatr Pharmacother 2007;5(1):31-9.

Rozenfeld S, Fonseca MJ, Acurcio FA. Drug utilization and polypharmacy among the elderly: a survey in Rio de Janeiro City, Brazil. Rev Panam Salud Publica 2008;23(1):34-43.

Nobili A, Garattini S, Mannucci PM. Multiple diseases and polypharmacy in the elderly: challenges for the internist of the third millennium. J Comorbidity 2011;1(1):28-44.

Anthierens S, Tansens A, Petrovic M, Christiaens T. Qualitative insights into general practitioners views on polypharmacy. BMC Fam Pract 2010;11:65.

Miller RK, Nelson MS, Spurlock BW. A compendium of suggested practices for preventing and reducing medication errors. Sacramento, CA: California Institute for Health Systems Performance, 2001.

Stawicki SP, Gerlach AT. Polypharmacy and medication errors: stop, listen, look and analyse. OPUS 12 Scientist 2009;3(1):6-10.

Varkey P, Cunningham J, O'Meara J, Bonacci R, Desai N, Sheeler R. Multidisciplinary approach to inpatient medication reconciliation in an academic setting. Am J Health Syst Pharm 2007;64(8):850-4.

Spinewine A, Schmader KE, Barber N, Hughes C, Lapane KL, Swine C, Hanlon JT. Appropriate prescribing in elderly people: how well can it be measured and optimised? Lancet 2007;370(9582):173-84.

Straand J, Fetveit A, Rognstad S, Gjelstad S, Brekke M, Dalen I. A cluster-randomized educational intervention to reduce inappropriate prescription patterns for elderly patients in general practice--The Prescription Peer Academic Detailing (Rx-PAD) study [NCT00281450]. BMC Health Serv Res 2006;6:72.

Taft SH, Pierce CA, Gallo CL. From hospital to home and back again: a study in hospital admissions and deaths for homecare patients. Home Health Care Manag Pract 2005;17(6):467-80.

Flaherty JH, Perry HM 3rd, Lynchard GS, Morley JE. Polypharmacy and hospitalization among older home care patients. J Gerontol A Biol Sci Med Sci 2000;55(10):M554-9.

Oepen G. Polypharamcy in schizophrenia. In: Ghaemi SN, editor. Polypharmacy in Psychiatry. New York, NY: Marcel Dekker; 2002. p. 1-34.

Sim K, Su A, Fujii S, Yang SY, Chong MY, Ungvari GS, Si T, Chung EK, Tsang HY, Chan YH, Heckers S, Shinfuku N, Tan CH. Antipsychotic polypharmacy in patients with schizophrenia: a multicentre comparative study in East Asia. Br J Clin Pharmacol 2004;58(2):178-83.

Jackson SH, Mangoni AA, Batty GM. Optimization of drug prescribing. Br J Clin Pharmacol 2004;57(3):231-6.

Gurwitz JH. Polypharmacy: a new paradigm for quality drug therapy in the elderly? Arch Intern Med 2004;164(18):1957-9.

How to Cite
1.
Lisha Jenny J, Jenny C, Jayadevan S, Jayakumary M, Mohamed A, Arun S, Mohamed FM. Nurses Opinion on the Attributes of Polypharmacy in Patient Safety. Acta Med Iran. 50(7):516-521.
QRcode
Section
Articles